Clinical trials
Phase 2/3 COVID-19 trials in Indonesia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advagene Biopharma Co. Ltd. | 1 |
| Australian National University | 1 |
| Dermama Bioteknologi Laboratorium | 1 |
| Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia | 1 |
| National Institute of Health Research and Development, Ministry of Health Republic of Indonesia | 1 |
| PT Bio Farma | 1 |
| Research Center for Chemistry, National Research and Innovation Agency of Indonesia | 1 |
| Staidson (Beijing) Biopharmaceuticals Co., Ltd | 1 |
| Suzhou Abogen Biosciences Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 9 |
| Cytokine Release Syndrome | 1 |
| Lymphoma, Follicular | 1 |
| Pneumonia | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.